"The consistency that I'm hearing from all across patient groups is gain of control, whereas previously, there was a loss of control," Gitanjali Srivastava, MD, an internist and director of the obesity medicine program at Vanderbilt University Medical Center in Nashville, Tennessee, told MedPage Today
10.1016/j.arr.2019.100914 7 ArbeevK
Whether you are dealing with a missed dose, managing side effects, or wondering if it is time to adjust your dosage, having 24/7 access to specialist support ensures you never have to guess about your health
This is a sharp analysis of why the GLP-1 race is a 'capability' play rather than just a 'commodity' play, especially given the high barriers in peptide API manufacturing and device calibration